2.16BMarket Cap
LossP/E TTM
Institutional Confidence
Currency: USD Updated: 2026-06-18The current institutional shareholding score of Celldex Therapeutics Inc is 10.00, ranking 1 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 96.30%, representing a quarter-over-quarter decrease of 26.99%. The largest institutional shareholder is Bill Nygren | OAKMX, holding a total of 3.24M shares, representing 4.85% of shares outstanding, with 18.49% decrease in holdings.
Institutional Shareholding
Shareholder Activity
Wellington Management Company, LLP
Kynam Capital Management LP
BlackRock Institutional Trust Company, N.A.
Bellevue Asset Management AG
Fidelity Management & Research Company LLC
State Street Investment Management (US)